Posted on 11/9/16
Better Buy: Amgen Inc. vs. Johnson & Johnson
They're two of the premiere long-term winners among healthcare stocks. They both have deep pipelines and deep pocketbooks. And they both reward investors with nice dividends. . . .
Posted on 11/8/16
Cognizant Technology Sees Profit Growth Ahead
Many corporate customers turn to Cognizant Technology Solutions (NASDAQ:CTSH) to help them make better use of the information technology resources that have become available in recent . . .
Posted on 11/8/16
Here's Why Amicus Therapeutics, Inc. Soared As Much As 20% Despite an Earnings Miss
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Amicus Therapeutics (NASDAQ:FOLD), a biopharmaceutical company focused on the development of therapies primarily designed to treat ultra-rare and rare diseases, . . .
Posted on 11/8/16
Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?
IMAGE SOURCE: GETTY IMAGES.What happenedShares of global drug giant Pfizer (NYSE:PFE) had a pretty miserable October, ending lower by 6.4% based on data from S&P Global . . .
Posted on 11/8/16
Celldex Therapeutics, Inc. Watches Its Cash in Q3, Ready to Expand
IMAGE SOURCE: GETTY IMAGES.There hasn't been much good news for Celldex Therapeutics (NASDAQ:CLDX) in 2016. Failure of Rintega in a late-stage study resulted in a loss . . .
Posted on 11/8/16
Celldex Reports Third Quarter 2016 Results
HAMPTON, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2016.“Celldex . . .
Posted on 11/8/16
SAFE-BioPharma Partnership Named Winner of HHS "Move Health Data Forward Challenge"
TEANECK, N.J.--(BUSINESS WIRE)--The Department of Health and Humans Services’ Office of the National Coordinator for Health Information Technology (ONC) named a proposal from SAFE-BioPharma, Resilient Network . . .
Posted on 11/7/16
Cognizant Announces Third Quarter 2016 Results
Cognizant Technology Solutions Corporation (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process services, today announced its third quarter 2016 financial results.Highlights—Third Quarter . . .
Posted on 11/7/16
Why Teva Pharmaceutical Shares Dropped 7% in October
IMAGE SOURCE: GETTY IMAGES.What happenedAfter U.S. patent regulators invalidated the third of five patents protecting Copaxone sales, shares in Teva Pharmaceutical (NYSE:TEVA) fell steadily throughout October . . .
Posted on 11/7/16
BackBeat Medical Wins Top Honor in TCT 2016 Shark Tank Innovation Competition
BackBeat Medical Inc. today announced that the company's patented Programmable Hypertension Control (PHC) therapy received first place in the Shark Tank Innovation Competition at the Transcatheter . . .
Posted on 11/7/16
Recovery Centers of America Opens First Drug and Alcohol Rehabilitation Center in Massachusetts
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Today,Recovery Centers of America (RCA)opens its newest drug and alcohol rehabilitation facility in Westminster, which will accept most major insurance plans, and . . .
Posted on 11/4/16
Novartis Takes Aim at Pfizer
Novartis' (NYSE:NVS) application for FDA approval of ribociclib for first-line use alongside letrozole, in patients who have advanced breast cancer with an amenable genetic makeup, has . . .
Posted on 11/4/16
Why Celgene Corp Is a Better Buy Than Gilead Sciences
IMAGE SOURCE: GETTY IMAGES.Over the past five years, there have perhaps been no large-cap biotech companies that have been as successful as Celgene Corp. (NASDAQ:CELG) and . . .
Posted on 11/4/16
Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Spark Therapeutics (NASDAQ:ONCE), a clinical-stage gene therapy company, plunged as much as 25% during Thursday afternoon's trading session, after Spark . . .
Posted on 11/4/16
Amerigroup New Jersey Joins National Comprehensive Primary Care Plus Initiative
ISELIN, N.J.--(BUSINESS WIRE)--Amerigroup New Jersey has been selected as a payer participant in the Centers for Medicare & Medicaid Services’ Comprehensive Primary Care Plus (CPC+) initiative, . . .
Posted on 11/3/16
Aclaris Therapeutics Reports Third Quarter 2016 Financial Results
MALVERN, Pa., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced financial results for the third quarter and . . .
Posted on 11/3/16
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2016 Financial Results
RADNOR, Pa., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 11/3/16
Pfizer Delivers Another Solid Quarter Of Organic Growth
IMAGE SOURCE: PFIZER, INC.Pfizer Inc.'s (NYSE:PFE) third-quarter performance shows that the company's finally overcoming the multiyear drag on sales caused by the patent expiration of Lipitor . . .
Posted on 11/2/16
Recovery Centers of America Opens Bracebridge Hall in Maryland
EARLEVILLE, Md.--(BUSINESS WIRE)--As 40 million Americans suffer from anxiety disorders and almost 23 million Americans struggle with addiction issues, Bracebridge Hall, a Recovery Centers of America . . .
Posted on 11/2/16
Pacira Pharmaceuticals Reports Third Quarter 2016 Financial Results
PARSIPPANY, N.J., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc.(NASDAQ:PCRX) today provided updates on EXPAREL® (bupivacaine liposome injectable suspension) for postsurgical pain in the United . . .
Posted on 11/2/16
Better Robotic Surgery Buy: TransEnterix, Inc. vs. Johnson & Johnson
IMAGE SOURCE: GETTY IMAGES.The robotic-surgery space is forecast to explode at a compound annual growth rate of more than 22% over the next five years, making . . .
Posted on 11/2/16
Here Are Johnson & Johnson's Next 10 Potential Blockbuster Drugs
IMAGE SOURCE: GETTY IMAGES.When it comes to steady investments, there may be no rock more solid in the healthcare space than Johnson & Johnson (NYSE:JNJ).Johnson & . . .
Posted on 11/2/16
Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters
IMAGE SOURCE: GETTY IMAGES.Pfizer Inc. (NYSE:PFE) has unexpectedly shuttered development of a high-profile cholesterol-lowering drug that works similarly to Amgen Inc.'s (NASDAQ:AMGN) Repatha and Regeneron Pharmaceuticals . . .
Posted on 11/2/16
3 Things You Really Need to Know About Pfizer's Q3 Results
Investors had gotten used to Pfizer (NYSE:PFE) beating earnings estimates each quarter. But all good things come to an end. The big drugmaker announced its third-quarter . . .
Posted on 11/1/16
Edge Therapeutics Reports Third Quarter Financial Results
BERKELEY HEIGHTS, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, . . .
Philadelphia
